| __timestamp | Genmab A/S | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 850385000 | 1162636000 |
| Thursday, January 1, 2015 | 1133041000 | 1396725000 |
| Friday, January 1, 2016 | 1816122000 | 1526100000 |
| Sunday, January 1, 2017 | 2365436000 | 1619600000 |
| Monday, January 1, 2018 | 3025137000 | 1429100000 |
| Tuesday, January 1, 2019 | 5366000000 | 1331200000 |
| Wednesday, January 1, 2020 | 10111000000 | 1375200000 |
| Friday, January 1, 2021 | 8482000000 | 1563000000 |
| Saturday, January 1, 2022 | 14595000000 | 1789600000 |
| Sunday, January 1, 2023 | 16248000000 | 2070000000 |
| Monday, January 1, 2024 | 20541000000 |
Unlocking the unknown
In the competitive world of biotechnology, financial performance is a key indicator of success. Over the past decade, Genmab A/S and United Therapeutics Corporation have been vying for dominance in gross profit generation. From 2014 to 2023, Genmab A/S has consistently outperformed its competitor, with a staggering 1,800% increase in gross profit, peaking at approximately 16.25 billion in 2023. In contrast, United Therapeutics Corporation saw a more modest growth of around 78%, reaching 2.07 billion in the same year. This remarkable disparity highlights Genmab's strategic prowess and market adaptability. As the biotech industry continues to evolve, these financial trends offer valuable insights into the companies' operational efficiencies and market strategies. Investors and industry analysts alike should keep a close eye on these two giants as they navigate the ever-changing landscape of biotechnology.
Gross Profit Comparison: Merck & Co., Inc. and Genmab A/S Trends
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Genmab A/S
Gross Profit Trends Compared: Zoetis Inc. vs United Therapeutics Corporation
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
Gross Profit Analysis: Comparing United Therapeutics Corporation and Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? United Therapeutics Corporation or Veracyte, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Genmab A/S vs Bio-Techne Corporation: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Genmab A/S vs Jazz Pharmaceuticals plc
Who Generates Higher Gross Profit? Genmab A/S or Travere Therapeutics, Inc.